CD274 and pneumonitis: Our subgroup analyses revealed that the incidence of mild pneumonitis was higher in patients who received PD‐L1 inhibitors than in those who received PD‐1 inhibitors; however, no significant intergroup difference was observed (Cross p = 0.180).